Milestone Scientific (MLSS)
XASE:MLSS
Earnings Data
Report Date
May 14, 2026TBA (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
―Last Year’s EPS
-0.02Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The call highlighted clear progress: restructuring and cost actions led to improved operating losses, modest revenue growth, renewed commercial focus (digital marketing, Ambassador program) and an actionable plan for CompuFlo reimbursement and market expansion. Management provided concrete 2026 guidance ($9.8M–$10.2M) and a target to reach cash flow breakeven by early 2027. However, significant risks remain — cash on hand is limited ($1.1M), the company remains loss-making (full-year net loss $5.7M), gross profit was flat year-over-year, and key upside depends on regulatory approvals, reimbursement expansion and successful conversion of early commercial programs. Overall, positives and improvements are tangible but balanced by near-term liquidity and execution risks.Company Guidance
Revenue Growth — Q4 and Full Year 2025
Total revenue for Q4 2025 was $2.1M, up 2.2% ($45k) versus Q4 2024. Full-year net sales were $9.0M, up 4% from $8.6M in 2024.
Large Improvement in Quarterly Operating Loss
Q4 operating loss improved to $1.1M, an 89% improvement (improvement of $953k) compared to an operating loss of $2.0M in the prior-year quarter.
Reduced Full-Year Operating Loss and Cost Actions
Full-year operating losses improved by $1.1M to $5.7M (from $6.8M in 2024), driven primarily by lower SG&A, reduced dental-related and R&D expense after restructuring and targeted cost actions.
2026 Guidance and Growth Expectations
Company guided 2026 revenue to $9.8M–$10.2M, calling for double-digit year-over-year growth. Management expects CompuFlo to contribute $500k–$600k in 2026, about a ~400% increase over 2025, and expects improved operating leverage and meaningfully reduced cash burn.
Commercial Initiatives and Early Traction
Restructuring completed in 2025 enabled a shift to targeted digital marketing and commercial investments. The Wand Ambassador program scaled nationally (pilot in Dec, national in Jan '26) with ~175 ambassadors signed and ~30 demos generated so far; expected to contribute a few hundred thousand dollars in new dental sales in 2026.
CompuFlo Commercial and Reimbursement Progress
CompuFlo commercialization was relaunched: introduced CompuFlo Advisor program (more than 10 physician partners), built reimbursement support with two Medicare veterans and a 3–4 person call center, and is pursuing broader Medicare reimbursement, VA channels and new distribution partners.
Gross Margin Target and Stability
Management expects to sustain gross margins roughly in the 70% range; Q4 gross profit was $1.5M, unchanged year-over-year.
MLSS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
MLSS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Mar 31, 2026 | $0.29 | $0.30 | +3.47% |
Nov 13, 2025 | $0.38 | $0.33 | -12.93% |
Aug 14, 2025 | $0.58 | $0.65 | +12.26% |
May 15, 2025 | $0.93 | $0.90 | -3.76% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Milestone Scientific (MLSS) report earnings?
Milestone Scientific (MLSS) is schdueled to report earning on May 14, 2026, TBA (Confirmed).
What is Milestone Scientific (MLSS) earnings time?
Milestone Scientific (MLSS) earnings time is at May 14, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is MLSS EPS forecast?
Currently, no data Available